Arthur Hayes Leads $6.9M Raise for BIO Protocol

Arthur Hayes, current CIO of the Maelstrom Fund, is doubling down on decentralized science, with his firm leading a nearly $7 million seed investment into Bio Protocol.
What’s the Scoop?
- $6.9M for DeSci’s New Star: Bio Protocol’s seed raise was anchored by Maelstrom, with Mechanism Capital, Animoca Brands, and Atria Ventures joining in.
- Hayes Sees a New Launchpad: Calling Bio “a category-defining launchpad,” Hayes said it aims to fund research based on community appeal rather than academic gatekeeping. If successful, it could birth a new AI-native research market.
- AI-Powered Science Agents: Bio Protocol’s platform allows users to deploy BioAgents – autonomous AI “co-scientists” that generate hypotheses, manage wallets, and commercialize discoveries.
